rss
J Med Ethics 2004;30:341-343 doi:10.1136/jme.2003.005017
  • Symposium on drugs

Further ethical and social issues in using a cocaine vaccine: response to Hall and Carter

  1. R E Ashcroft1,
  2. C Franey2
  1. 1Department of Primary Health Care and General Practice, Imperial College London, London, UK
  2. 2Department of Social Science and Medicine, Imperial College London, London, UK
  1. Correspondence to:
 Dr R Ashcroft
 Imperial College London, Medical Ethics Unit, 324 Reynolds Building, St Dunstan’s Road, London W6 8RP, UK; r.ashcroftimperial.ac.uk
  • Received 18 October 2003
  • Accepted 13 April 2004
  • Revised 2 April 2004

Abstract

Evaluation of the potential of a cocaine vaccine requires a detailed understanding of the intended and unintended social consequences of its use. Prospective technology assessment is always difficult, but in the case of treatment and prevention of cocaine addiction we need to understand not only the neuroscience and pharmacology of cocaine addiction, but also social attitudes to drug use and addiction, the social context of drug use, and the factors which make drug use a rational strategy for an addict and make treatment seeking or relapse more or less likely. By considering different scenarios related to differing levels of effectiveness of the vaccine, the authors argue that vaccination will be at best a useful adjunct to existing methods of treatment, rather than a substitute for them.

Footnotes

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.